Release R DES
Coronary artery disease
CommercialActive
Key Facts
About Relisys Medical Devices
India’s leading affordable cardiovascular device maker with end‑to‑end stent and valve manufacturing.
View full company profileTherapeutic Areas
Other Coronary artery disease Drugs
| Drug | Company | Phase |
|---|---|---|
| MUTI™ Drug‑Eluting Stent | Meril | Commercial |
| Coronary Artery Bypass Grafts | Vascudyne | Pre-clinical |
| Premier DES | Relisys Medical Devices | Commercial |
| Pristine DES | Relisys Medical Devices | Commercial |
| BioMatrix family (Flex/Alpha) | Biosensors International | Commercial |
| Coronary Artery Disease Program | Elixir Medical | Pre-clinical |
| Essential pro Stent | iVascularU | Post-Market |
| FGF-1 | Zhittya Genesis Medicine | Phase 2 |
| OMT-28 | OMEICOS Therapeutics | Phase 2 |
| Fantom Encore | REVA Medical | Commercial |
| Next-Gen Drug-Eluting Stents | Translumina | Development |
| Geographic Market Expansion | Translumina | Commercial |